Ching-Yung Lin

CEO
Graphen Drugomics, Inc.

​​​​

Dr. Ching-Yung Lin founded Graphen, Inc. in 2017. Graphen's mission is to develop State-of-the-art AI technology for the well-being of mankind. He also serves as the CEO of Graphen Drugomics, Inc., an AI drug design and development subsidiary of Graphen. Headquartered in New York, Graphen has subsidiaries in Taipei, Tokyo, Hong Kong, Singapore, and Beijing. 
In 2020, the ABI medical white paper selected Graphen, Google, and NVidia as the companies that would have the most significant impact on drug development. Graphen combines AI graph network computing, deep learning and generative AI to develop the Graphen Atom, an end-to-end AI drug design system of protein structure, function and binding prediction, digestion and absorption metabolism model prediction, genome reasoning, etc., for generating new drug candidates with high specificity and low side effects. It was estimated to be 27x faster than traditional drug design process. 

 
Dr. Lin has been an adjunct professor in Columbia University since 2005. Prior to founding Graphen, he was the Chief Scientist at IBM Corp and founder of the Network Science and Machine Intelligence Group at the IBM T. J. Watson Research Center. He was appointed an IEEE Fellow in 2011. He has also been an adjunct professor at New York University (2014) and the University of Washington (2003-2009). In the past 20+ years, he has led tens of large-scale global AI projects deployed in the United States, EU, China, Russia and Southeast Asia. ​


Dr. Lin has been an invited keynote speaker at more than 70 conferences, including serving as a co-speaker with the White House Chief Data Scientist at the 2015 American Medical Association Annual Meeting. He is the author or co-author of more than 200 publications, holds 75+ patents, cited approximately 13,000 times, and has an h-index of 57. He was the 2009-10 Chair of IEEE CAS Multimedia TC and the General Chair of the 2009 IEEE International Multimedia Conference. Dr. Lin's work has received 7 best paper awards and been featured four times in BusinessWeek magazine, including as a cover story in May 2009. In 2010, the IBM Career Review selected Dr. Lin as "a scientist most likely to have the greatest scientific impact on IBM and the world."

Speech title & Synopsis

Panel Discussion

Moderator